---
layout: post
title: "Cuffless Non-Invasive Blood Pressure Measuring Devices-Clinical Performance Testing and Evaluation; Draft Guidance for Industry and Food and Drug Administration Staff; Availability"
date: 2026-02-04 21:14:52 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2026-01288
original_published: 2026-01-23 00:00:00 +0000
significance: 8.00
---

# Cuffless Non-Invasive Blood Pressure Measuring Devices-Clinical Performance Testing and Evaluation; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

**Published:** February 04, 2026 21:14 UTC
**Source:** Federal Register
**Original Published:** January 23, 2026 00:00 UTC
**Document Number:** 2026-01288

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled "Cuffless Non-invasive Blood Pressure Measuring Devices--Clinical Performance Testing and Evaluation." This draft guidance provides recommendations for clinical performance testing and evaluation to support premarket submissions for cuffless non-invasive blood pressure measuring devices. This draft guidance is not final nor is it for implementation at this time.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2026/01/23/2026-01288/cuffless-non-invasive-blood-pressure-measuring-devices-clinical-performance-testing-and-evaluation)
- API: https://www.federalregister.gov/api/v1/documents/2026-01288

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
